Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease
Trial
Phase 3
Completed
Jan. 18, 2009
Botulinum A Toxin in Patients With Parkinson's Disease
Trial
Phase 4
Unknown
Jan. 14, 2009
Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
Trial
Phase 2
Completed
Jan. 13, 2009
Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease
Trial
Phase 2
Completed
Jan. 8, 2009
Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD)
Trial
Phase 1
Unknown
Jan. 4, 2009
Diagnostic and Prognostic Biomarkers in Parkinson Disease
Trial
N/A
Unknown
Dec. 30, 2008
Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease
Trial
Phase 2
Completed
Dec. 22, 2008
Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease
Trial
Phase 2
Completed
Dec. 22, 2008
Mechanisms of Fronto-Subcortical Dysfunction: Comparing PD and OCD
Trial
N/A
Unknown
Nov. 12, 2008
2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD
Trial
Phase 2
Completed
Nov. 6, 2008
Impact of Deep Brain Stimulation of Subthalamic Nucleus on the Hepatic Glucose Production in Parkinson's Disease
Trial
N/A
Terminated
Oct. 7, 2008
Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
Trial
Phase 1
Unknown
Oct. 6, 2008
Fipamezole in Neurogenic Orthostatic Hypotension
Trial
Phase 2
Unknown
Sept. 30, 2008
Efficiency of Physiotherapeutic Care in Parkinson's Disease
Trial
Phase 3
Completed
Sept. 2, 2008
SLV308 for Treatment of Patients With Early Parkinson's Disease
Trial
Phase 3
Completed
Aug. 28, 2008
Automatic Recognition of Freezing of Gait Episodes
Trial
N/A
Unknown
Aug. 19, 2008
A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
Trial
N/A
Completed
Aug. 13, 2008
Bio-Feedback to Improving Stability in Elderly Population
Trial
N/A
Unknown
July 15, 2008
PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
Trial
Phase 2
Terminated
June 15, 2008